OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stem cell therapy in coronavirus disease 2019: current evidence and future potential
Rohit Shetty, Ponnalagu Murugeswari, Koushik Chakrabarty, et al.
Cytotherapy (2020) Vol. 23, Iss. 6, pp. 471-482
Open Access | Times Cited: 13

Showing 13 citing articles:

Contribution of machine learning approaches in response to SARS-CoV-2 infection
Mohammad Sadeq Mottaqi, Fatemeh Mohammadipanah, Hedieh Sajedi
Informatics in Medicine Unlocked (2021) Vol. 23, pp. 100526-100526
Open Access | Times Cited: 46

Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment
Arefeh Basiri, Fatemeh Mansouri, Arezo Azari, et al.
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 1, pp. 193-213
Open Access | Times Cited: 45

Mesenchymal Stem Cell-Derived Exosome Therapy of Microbial Diseases: From Bench to Bed
Xiaolan Wu, Shanshan Jin, Chengye Ding, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 21

Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects: Update from 2015 review
Leah A. Marquez‐Curtis, Janet A.W. Elliott
Cryobiology (2024) Vol. 115, pp. 104856-104856
Open Access | Times Cited: 4

Non-antiviral therapies for viral infections: Harnessing host mechanisms
Sruthi Sarvepalli, Shubhadeepthi Vadarevu
International Immunopharmacology (2025) Vol. 153, pp. 114521-114521
Closed Access

Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era
Birbal Singh, Gorakh Mal, Vinod Verma, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 27

Differential response of mesenchymal stromal cells (MSCs) to type 1 ex vivo cytokine priming: implications for MSC therapy
Andre J. Burnham, Elisabetta Manuela Foppiani, Kyndal Goss, et al.
Cytotherapy (2023) Vol. 25, Iss. 12, pp. 1277-1284
Closed Access | Times Cited: 8

Editorial: Emerging talents in alloimmunity and transplantation: 2022
Guido Moll, Wai H. Lim, Olaf Penack
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Specific Activation of T Cells by an ACE2-Based CAR-Like Receptor upon Recognition of SARS-CoV-2 Spike Protein
Pablo Gonzalez-Garcia, Juan Pedro Muñoz-Miranda, Ricardo Fernández-Cisnal, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7641-7641
Open Access | Times Cited: 6

An outlook on antigen-specific adoptive immunotherapy for viral infections with a focus on COVID-19
Seyed Mostafa Monzavi, Mahmood Naderi, Naser Ahmadbeigi, et al.
Cellular Immunology (2021) Vol. 367, pp. 104398-104398
Open Access | Times Cited: 9

Stem cell-driven tissue regeneration as treatment for COVID-19
Jane Joy Thomas, Jessy John, Mereena George Ushakumary
Elsevier eBooks (2022), pp. 125-138
Closed Access

Page 1

Scroll to top